INFORMATIONAL PURPOSES ONLY. Not medical, legal, or travel advice. Verify with official sources before acting. See corrections log.

Medical Freedom Maps

Home » Maps » Regenerative medicine » Limit Practitioner Scope for Cell Therapies

States where limit practitioner scope for cell therapies

State-by-state comparison: limit practitioner scope for cell therapies. Interactive map and sortable table for all 50 US states.

StateValueVerifiedSource
AlaskaNo explicit state provision; federal framework applies.2026-10-09Source
AlabamaNo explicit state provision; federal framework applies.2026-10-09Source
ArkansasNo explicit state provision; federal framework applies.2026-10-09Source
ArizonaNo explicit state provision; federal framework applies.2026-10-09Source
CaliforniaNotice duty applies to any health care practitioner licensed under Division 2 of the Business and Professions Code who performs non-FDA-approved stem cell therapy (exempt under an FDA IND/IDE); the statute does not authorize the therapy or limit it to MD/DO.2026-10-09Source
ColoradoNo explicit state provision; federal framework applies.2026-10-09Source
ConnecticutNo explicit state provision; federal framework applies.2026-10-09Source
District of ColumbiaNo explicit state provision; federal framework applies.2026-10-09Source
DelawareNo explicit state provision; federal framework applies.2026-10-09Source
FloridaAllopathic (ch. 458) and osteopathic (ch. 459) physicians, within their scope of practice, for orthopedics, wound care, or pain management; since June 2026 also podiatric physicians (§ 461.011) for connective tissue, ligament and tendon repair, wound care, or pain management. Cells must come from FDA-registered facilities accredited by NMDP, WMDA, AABB or AATB; signed consent required.2026-10-09Source
GeorgiaPhysicians licensed under Georgia's medical practice act or, on the physician's lawful designation, a physician assistant or nurse practitioner, within scope of practice; signed patient consent required; cells from FDA-registered or WMDA/AABB/AATB-accredited facilities.2026-10-09Source
HawaiiNo explicit state provision; federal framework applies.2026-10-09Source
IowaNo explicit state provision; federal framework applies.2026-10-09Source
IdahoNo explicit state provision; federal framework applies.2026-10-09Source
IllinoisNo explicit state provision; federal framework applies.2026-10-09Source
IndianaNo explicit state provision; federal framework applies.2026-10-09Source
KansasNo explicit state provision; federal framework applies.2026-10-09Source
KentuckyNo explicit state provision; federal framework applies.2026-10-09Source
LouisianaNo explicit state provision; federal framework applies.2026-10-09Source
MassachusettsNo explicit state provision; federal framework applies.2026-10-09Source
MarylandNo explicit state provision; federal framework applies.2026-10-09Source
MaineNo explicit state provision; federal framework applies.2026-10-09Source
MichiganNo explicit state provision; federal framework applies.2026-10-09Source
MinnesotaNo explicit state provision; federal framework applies.2026-10-09Source
MissouriNo explicit state provision; federal framework applies.2026-10-09Source
MississippiRequires a physician's prescription or recommendation; statute does not specify who administers. Product must be IRB-approved or in an FDA/NIH-approved protocol, have completed phase 1, and remain under investigation.2026-10-09Source
MontanaNo stem-cell-specific provision. Under the general Right to Try Act, experimental treatments may be provided by physicians, prescribing APRNs, physician assistants, and registered nurses at experimental treatment centers.2026-10-09Source
North CarolinaPhysician must administer; protocol approved by an IRB (affiliated with a medical school or its affiliated facility), with annual IRB reports to the NC Medical Board.2026-10-09Source
North DakotaNo explicit state provision; federal framework applies.2026-10-09Source
NebraskaNotice/consent duty applies to any health care practitioner licensed or certified under the Uniform Credentialing Act who performs stem-cell-based therapy; FDA-approved products and FDA IND/IDE therapies are exempt.2026-10-09Source
New HampshireNo explicit state provision; federal framework applies.2026-10-09Source
New JerseyNo explicit state provision; federal framework applies.2026-10-09Source
New MexicoNo explicit state provision; federal framework applies.2026-10-09Source
NevadaNo explicit state provision; federal framework applies.2026-10-09Source
New YorkNo explicit state provision; federal framework applies.2026-10-09Source
OhioNo explicit state provision; federal framework applies.2026-10-09Source
OklahomaNo explicit state provision; federal framework applies.2026-10-09Source
OregonNo explicit state provision; federal framework applies.2026-10-09Source
PennsylvaniaNo explicit state provision; federal framework applies.2026-10-09Source
Rhode IslandNo explicit state provision; federal framework applies.2026-10-09Source
South CarolinaNo explicit state provision; federal framework applies.2026-10-09Source
South DakotaNo explicit state provision; federal framework applies.2026-10-09Source
TennesseePhysicians (licensed under Tenn. Code Ann. title 63, chapter 6 or 9, i.e. MD or DO), for treatments within the physician's scope of practice; products must come from compliant facilities.2026-10-09Source
TexasMD/DO; IRB oversight2026-10-09Source
UtahAny health care provider (as defined in Utah Code § 78B-3-403) whose scope of practice includes stem cell therapy; written notice and signed consent required.2026-10-09Source
VirginiaNo explicit state provision; federal framework applies.2026-10-09Source
VermontNo stem-cell-specific limit on who may administer; notice and disclosure duties apply to any health care practitioner licensed by the Board of Medical Practice or the Office of Professional Regulation.2026-10-09Source
WashingtonNo stem-cell-specific limit on who may administer; notice and consent duties apply to any license holder under the Uniform Disciplinary Act (RCW 18.130) who performs non-FDA-approved stem cell therapy.2026-10-09Source
WisconsinNo explicit state provision; federal framework applies.2026-10-09Source
West VirginiaNo explicit state provision; federal framework applies.2026-10-09Source
WyomingPhysicians licensed by the Wyoming state board of medicine (not physician assistants) who are registered with the board to provide stem cell therapy; administered by or under direct supervision of a physician.2026-10-09Source

Embed This Map

Add an interactive map to your site. Always stays current.

Methodology: every value was checked in October 2026 against a specific source (statute, regulator or official list, or a named tracker page), and each links to that page with a short quote. Values no source could support are shown as “Not verified”. Verification was AI-assisted and spot-checked; laws change, so confirm with the linked source before relying on a value. How values are verified · Report an error.